The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications
Abstract
Prokaryotic expression systems are superior in producing valuable recombinant proteins, enzymes and therapeutic products. Conventional microbial technology is evolving gradually and amalgamated with advanced technologies in order to give rise to improved processes for the production of metabolites, recombinant biopharmaceuticals and industrial enzymes. Recently, several novel approaches have been employed in a bacterial expression platform to improve recombinant protein expression. These approaches involve metabolic engineering, use of strong promoters, novel vector elements such as inducers and enhancers, protein tags, secretion signals, high-throughput devices for cloning and process screening as well as fermentation technologies. Advancement of the novel technologies in E. coli systems led to the production of "difficult to express" complex products including small peptides, antibody fragments, few proteins and full-length aglycosylated monoclonal antibodies in considerable large quantity. Wacker's secretion technologies, Pfenex system, inducers, cell-free systems, strain engineering for post-translational modification, such as disulfide bridging and bacterial N-glycosylation, are still under evaluation for the production of complex proteins and peptides in E. coli in an efficient manner. This appraisal provides an impression of expression technologies developed in recent times for enhanced production of heterologous proteins in E. coli which are of foremost importance for diverse applications in microbiology and biopharmaceutical production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foundations for engineering biology
Endy, D. (2005) · Nature · doi:10.1038/nature04342 · Cited by 1,511
Secretory and extracellular production of recombinant proteins using Escherichia coli
Choi, J. H., & Lee, S. Y. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1559-9 · Cited by 614
Cited by
Contemporary enzyme based technologies for bioremediation: A review
Sharma, B., Dangi, A. K., & Shukla, P. (2018) · Journal of Environmental Management · doi:10.1016/j.jenvman.2017.12.075 · Cited by 591
Self-citationTripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
Bioremediation through microbes: systems biology and metabolic engineering approach
Dangi, A. K., Sharma, B., Hill, R. T., & Shukla, P. (2019) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2018.1500997 · Cited by 318
Self-citationThe algal chloroplast as a synthetic biology platform for production of therapeutic proteins
Dyo, Y. M., & Purton, S. (2018) · Microbiology · doi:10.1099/mic.0.000599 · Cited by 140
E. coli strain engineering for the production of advanced biopharmaceutical products
Selas Castiñeiras, T., Williams, S. G., Hitchcock, A. G., & Smith, D. C. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny162 · Cited by 92
Metadata
- Authors
- Gupta, S. K., & Shukla, P.
- Venue
- Critical Reviews in Biotechnology
- Publisher
- Informa UK Limited
- Published
- 2015-09-18
- Volume
- 36
- Issue
- 6
- Pages
- 1089-1098
- ISSN
- 0738-8551 (ISSN-L)
- 1549-7801
- OpenAlex
- W2167574642
- Cited by
- 196
- References
- 2
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications. https://app.cochat.ai/papers/10.3109/07388551.2015.1084264
- The paper
- Gupta, S. K., & Shukla, P. (2016). Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications. Critical Reviews in Biotechnology. https://doi.org/10.3109/07388551.2015.1084264
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.